Curia partners with eXoZymes to scale up NCT manufacturing process

EXOZ•2026-09-08

Work to be carried out in Europe

The work will be carried out at Curia sites in León, Spain, and Rozzano, Italy.

Curia and eXoZymes sign manufacturing agreement

Curia Global signed an agreement with eXoZymes to support technology transfer and commercial-scale manufacturing scale-up for N-trans-caffeoyltyramine (NCT).

The program is slated to start in Q4 2026, setting a technical roadmap for larger-scale production in 2027.

Sources

Curia partners with eXoZymes to scale up NCT manufacturing process

Publicnow

Curia partners with eXoZymes to scale up NCT manufacturing process

Work to be carried out in Europe

Curia and eXoZymes sign manufacturing agreement

Related News

VersaBank releases transcript of fiscal 2026 third-quarter results conference call

BlackRock sticks with bullish emerging market debt call even as 2026 returns slow

Charter’s Spectrum partners with Southern Bank to build future-ready network

Sources

Curia partners with eXoZymes to scale up NCT manufacturing process

Meshflow Acquisition On Sep 5, Enters Agreement With HGP Intelligent Energy - SEC Filing

AstraZeneca publishes transcript of ERS 2026 investor call and webcast